Skip to content

PRESS RELEASES


PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary Integra LifeSciences Schedules Conference Call for Wed., August 2 to Discuss Second Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wed., August 2 to Discuss Second Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--July 7, 2006--Integra LifeSciences Holdings Corporation (NASDAQ:IART) has scheduled a conference call
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, April 28 to Discuss First Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, April 28 to Discuss First Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--April 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, February 27 to Discuss Fourth Quarter and Full Year 2001 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J. Feb. 20, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART) announced
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, February 28 to Discuss Fourth Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, February 28 to Discuss Fourth Quarter 2006 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J., Jan 22, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART)
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, July 28 to Discuss Second Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance PLAINSBORO, N.J.--(BUSINESS WIRE)--July 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference
View HTML
Toggle Summary Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance
Integra LifeSciences Schedules Conference Call for Wednesday, November 7 to Discuss Third Quarter 2001 Financial Results and Provide Forward-Looking Earnings Guidance PLAINSBORO, N.J., Oct 31, 2001 (BUSINESS WIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) announced that it has
View HTML
Toggle Summary Integra LifeSciences Selected for Healogics iSupply℠ Program
PLAINSBORO, N.J., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based tissue products within Healogics ® Inc. new iSupply program.
View HTML
Toggle Summary Integra LifeSciences Statement on the U.S. FDA Safety Communication on Acellular Dermal Matrix (ADM) Products Used in Implant-Based Breast Reconstruction
PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S.
View HTML
Toggle Summary Integra LifeSciences Supports Newest Edition of Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury
PLAINSBORO, N.J., Jun 28, 2007 (PrimeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today its support for the third edition of the Brain Trauma Foundation's Guidelines for the Management of Severe Traumatic Brain Injury (Guidelines).
View HTML
Toggle Summary Integra LifeSciences Supports Study On Spinal Cord Injuries
Integra LifeSciences Supports Study On Spinal Cord Injuries PLAINSBORO, N.J., April 2, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced its participation in a study published last month in the European Journal of Neuroscience.
View HTML